Munich, Germany

Yoshihiro Arakawa

This inventor holds 1 USPTO granted patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshihiro Arakawa. Retrieved from https://idiyas.com/inventor/yoshihiro-arakawa-q0nackoe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yoshihiro Arakawa: Innovator in Neurotrophic Factor Research

Introduction

Yoshihiro Arakawa is a prominent inventor based in Munich, Germany. He is known for his significant contributions to the field of neurobiology, particularly in the development of therapeutic proteins. His work has implications for various neurological conditions, showcasing the intersection of science and innovation.

Latest Patents

Yoshihiro Arakawa holds a patent for "DNA encoding human ciliary neurotrophic factor and method for producing the protein encoded thereby." This patent represents a crucial advancement in the understanding and application of neurotrophic factors, which are vital for the survival and function of neurons.

Career Highlights

Arakawa is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to push the boundaries of research in neurobiology. His work at Regeneron has allowed him to collaborate with leading scientists and contribute to groundbreaking discoveries in the field.

Collaborations

Throughout his career, Yoshihiro has worked alongside esteemed colleagues such as Michael Sendtner and Kurt Stockli-Rippstein. These collaborations have enriched his research and expanded the impact of his innovations in neurotrophic factor studies.

Conclusion

Yoshihiro Arakawa's contributions to the field of neurobiology through his patent and work at Regeneron Pharmaceuticals highlight the importance of innovation in medical research. His efforts continue to pave the way for advancements in treatments for neurological disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…